Achieve Life Sciences, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Achieve Life Sciences, Inc. (ACHV) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $8.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-24
- Achieve Life Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $8.60M, a 0.00% change from fiscal 2024.
- Achieve Life Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $8.60M, a 11.69% increase from fiscal 2023.
- Achieve Life Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $7.70M, a 25.96% decline from fiscal 2022.
- Achieve Life Sciences, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $10.40M, a 38.67% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $8.60M 10-K · filed 2026-03-24 |
| 2024-12-31 | $8.60M 10-K · filed 2025-03-11 |
| 2023-12-31 | $7.70M 10-K · filed 2024-03-28 |
| 2022-12-31 | $10.40M 10-K · filed 2023-03-16 |
| 2021-12-31 | $7.50M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |